NCT06880562 - The RESPLASH Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2026

Primary Completion Date

January 31, 2027

Study Completion Date

January 31, 2027

Conditions

Resistant Hypertension

Interventions

DEVICE

Splanchnic Nerve Denervation

Catheter-based endovascular denervation (CDN) of renal arteries and splanchnic nerves (celiac + SMA) using radiofrequency ablation

DEVICE

Renal Denervation Only

Catheter-based endovascular denervation (CDN) of renal arteries only, without splanchnic nerve denervation

Trial Locations (1)

East Jefferson General Hospital, New Orleans

All Listed Sponsors

lead

Tulane University

OTHER